These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37561732)

  • 1. Prioritizing COVID-19 vaccine allocation in resource poor settings: Towards an Artificial Intelligence-enabled and Geospatial-assisted decision support framework.
    Shayegh S; Andreu-Perez J; Akoth C; Bosch-Capblanch X; Dasgupta S; Falchetta G; Gregson S; Hammad AT; Herringer M; Kapkea F; Labella A; Lisciotto L; Martínez L; Macharia PM; Morales-Ruiz P; Murage N; Offeddu V; South A; Torbica A; Trentini F; Melegaro A
    PLoS One; 2023; 18(8):e0275037. PubMed ID: 37561732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations for fair prioritization of COVID-19 vaccine and its mandate among healthcare personnel.
    Hughes K; Gogineni V; Lewis C; Deshpande A
    Curr Med Res Opin; 2021 Jun; 37(6):907-909. PubMed ID: 33760673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea.
    Choi MJ; Choi WS; Seong H; Choi JY; Kim JH; Kim YJ; Cho EY; Kim DH; Park H; Lee H; Kim NJ; Song JY; Cheong HJ; Kim SI; Peck KR
    J Korean Med Sci; 2021 Jun; 36(23):e166. PubMed ID: 34128597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Intelligence-Enabled Social Media Analysis for Pharmacovigilance of COVID-19 Vaccinations in the United Kingdom: Observational Study.
    Hussain Z; Sheikh Z; Tahir A; Dashtipour K; Gogate M; Sheikh A; Hussain A
    JMIR Public Health Surveill; 2022 May; 8(5):e32543. PubMed ID: 35144240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing two-dose vaccine resource allocation to combat a pandemic in the context of limited supply: The case of COVID-19.
    Zhu J; Wang Q; Huang M
    Front Public Health; 2023; 11():1129183. PubMed ID: 37168073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial Intelligence-Enabled Analysis of Public Attitudes on Facebook and Twitter Toward COVID-19 Vaccines in the United Kingdom and the United States: Observational Study.
    Hussain A; Tahir A; Hussain Z; Sheikh Z; Gogate M; Dashtipour K; Ali A; Sheikh A
    J Med Internet Res; 2021 Apr; 23(4):e26627. PubMed ID: 33724919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Vaccination Prioritization Strategies for COVID-19 in South Africa Based on Age-Specific Compartment Model.
    Zuo C; Meng Z; Zhu F; Zheng Y; Ling Y
    Front Public Health; 2022; 10():876551. PubMed ID: 35784231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Views on COVID-19 vaccination among residents of Eldoret, Kenya during the 2021 vaccine rollout.
    Bosire EN; Cho A; Kamau LW; Bosire V; Mendenhall E
    Glob Public Health; 2023 Jan; 18(1):2278877. PubMed ID: 37967534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. County-Level COVID-19 Vaccination Coverage and Social Vulnerability - United States, December 14, 2020-March 1, 2021.
    Hughes MM; Wang A; Grossman MK; Pun E; Whiteman A; Deng L; Hallisey E; Sharpe JD; Ussery EN; Stokley S; Musial T; Weller DL; Murthy BP; Reynolds L; Gibbs-Scharf L; Harris L; Ritchey MD; Toblin RL
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(12):431-436. PubMed ID: 33764963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccination dynamics in the US: coverage velocity and carrying capacity based on socio-demographic vulnerability indices in California's pediatric population.
    Bruckhaus AA; Khan A; Pickering TA; Abedi A; Salehi S; Duncan D
    Front Public Health; 2023; 11():1148200. PubMed ID: 37228717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between social vulnerability and COVID-19 vaccination hesitancy and vaccination in pregnant and postpartum individuals.
    Kiefer MK; Mehl R; Rood KM; Germann K; Mallampati D; Manuck T; Costantine MM; Lynch CD; Grobman WA; Venkatesh KK
    Vaccine; 2022 Oct; 40(44):6344-6351. PubMed ID: 36167695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine sentiment analysis using BERT + NBSVM and geo-spatial approaches.
    Umair A; Masciari E; Ullah MH
    J Supercomput; 2023 May; ():1-31. PubMed ID: 37359330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Vaccination Dynamics in the US: Coverage Velocity and Carrying Capacity Based on Socio-demographic Vulnerability Indices in California.
    Bruckhaus AA; Abedi A; Salehi S; Pickering TA; Zhang Y; Martinez A; Lai M; Garner R; Duncan D
    J Immigr Minor Health; 2022 Feb; 24(1):18-30. PubMed ID: 34797451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An agent-based model to assess large-scale COVID-19 vaccination campaigns for the Italian territory: The case study of Lombardy region.
    Cattaneo A; Vitali A; Mazzoleni M; Previdi F
    Comput Methods Programs Biomed; 2022 Sep; 224():107029. PubMed ID: 35908330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions to increase COVID-19 vaccine uptake: a scoping review.
    Andreas M; Iannizzi C; Bohndorf E; Monsef I; Piechotta V; Meerpohl JJ; Skoetz N
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015270. PubMed ID: 35920693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An equitable vaccine delivery system: Lessons from the COVID-19 vaccine rollout in Canada.
    Kholina K; Harmon SHE; Graham JE
    PLoS One; 2022; 17(12):e0279929. PubMed ID: 36584230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of geo-political socio-economic factors on vaccine dissemination trends: a case-study on COVID-19 vaccination strategies.
    Chauhan R; Varma G; Yafi E; Zuhairi MF
    BMC Public Health; 2023 Nov; 23(1):2142. PubMed ID: 37919737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Priority Settings at the Start of COVID-19 Mass Vaccination on Subsequent Vaccine Uptake in Japan: One-Year Prospective Cohort Study.
    Hori D; Takahashi T; Ozaki A; Tabuchi T
    JMIR Public Health Surveill; 2023 Jul; 9():e42143. PubMed ID: 37235691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.